Tevogen Bio Holdings Inc. Warrant (TVGNW)

• Market cap: $11M
• 1 day: 3.63%
• 5 days: -15.49%
• 1 month: -0.83%
• 3 months: 14.29%
• 6 months: -10.31%
• Year to date: 0%
• 1 year: 233.33%
• 5 years: -86.67%
• 10 years: -86.67%
• Sector: Healthcare
• Industry: Biotechnology

About: Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Employees: 17

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

26% more capital invested

Capital invested by funds: $614K [Q1] → $774K (+$160K) [Q2]

0.55% less ownership

Funds ownership: 5.58% [Q1] → 5.03% (-0.55%) [Q2]

3% less funds holding

Funds holding: 37 [Q1] → 36 (-1) [Q2]

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

80% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 5